SANUWAVE Health, Inc.·4

Jul 2, 4:12 PM ET

Bazar Gregory Matthew 4

4 · SANUWAVE Health, Inc. · Filed Jul 2, 2026

Research Summary

AI-generated summary of this filing

Updated

SANUWAVE (SNVW) Director Gregory Bazar Receives 5,524-Share Award

What Happened
Gregory Matthew Bazar, a director of SANUWAVE Health, Inc. (SNVW), was granted derivative securities covering 5,524 shares on June 30, 2026. The Form 4 reports an acquisition price of $0.00 for the award; a footnote states the options were fully vested at the grant date. This filing records an award/acquisition (not a sale).

Key Details

  • Transaction date: 2026-06-30; Form 4 filed: 2026-07-02.
  • Transaction type: Grant / award of derivative securities (Form code A).
  • Shares/units involved: 5,524 (reported acquisition price $0.00).
  • Footnote: Options were fully vested at the grant date.
  • Shares owned following the transaction: Not specified in the filing.
  • No 10b5-1 plan, tax withholding, or cashless sale noted in this filing.

Context
The filing indicates these are derivative securities (options) granted and immediately vested. This is not an exercise or sale — it documents an award that gives the insider rights tied to 5,524 underlying shares. Awards can reflect compensation or retention arrangements; they do not by themselves indicate a sale of stock or immediate cash proceeds. If the options are exercised or underlying shares are later sold, subsequent filings would disclose those transactions.

Insider Transaction Report

Form 4
Period: 2026-06-30
Transactions
  • Award

    Stock Option (right to buy)

    [F1]
    2026-06-30+5,5245,524 total
    Exercise: $10.00Exp: 2031-06-30Common Stock (5,524 underlying)
Footnotes (1)
  • [F1]Options were fully vested at the grant date.
Signature
/s/ Griffin D. Foster, Attorney-in-Fact for Gregory Bazar|2026-07-02

Documents

1 file
  • 4
    form4-07022026_080740.xmlPrimary